Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
- Conditions
- Bladder Cancer
- Registration Number
- NCT00003725
- Lead Sponsor
- Anthra Pharmaceuticals
- Brief Summary
RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer and may have fewer side effects and improve recovery. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether transurethral resection plus AD 32 is more effective than transurethral resection alone for bladder cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of transurethral resection surgery followed by AD 32 with that of transurethral resection alone in treating patients who have newly diagnosed or recurrent bladder cancer.
- Detailed Description
OBJECTIVES: I. Assess the efficacy of adjuvant AD 32 following complete transurethral resection versus transurethral resection alone in patients with newly diagnosed or recurrent superficial transitional cell carcinoma of the bladder. II. Assess the toxicity of AD 32 in these patients.
OUTLINE: This is an open label, randomized, multicenter study. Patients are randomized to receive surgery with AD 32 or surgery alone. Arm I: Patients undergo surgery to remove bladder tumors. AD 32 is administered by catheter into the bladder within 2-24 hours after surgery. Patients must hold the AD 32 liquid in the bladder for 90 minutes. Arm II: Patients undergo only surgery to remove bladder tumors. Patients with T1 or Tis disease may receive BCG therapy once weekly for 6 weeks, followed by 6 weeks of rest. Patients are followed every 3 months for 2 years.
PROJECTED ACCRUAL: This study will accrue approximately 300 patients.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (52)
University of Chicago Cancer Research Center
๐บ๐ธChicago, Illinois, United States
Mississippi Urology Clinic, P.A.
๐บ๐ธJackson, Mississippi, United States
Wake Urological Associates
๐บ๐ธRaleigh, North Carolina, United States
Toronto General Hospital
๐จ๐ฆToronto, Ontario, Canada
West Virginia University Hospitals
๐บ๐ธMorgantown, West Virginia, United States
Louisiana State University Health Sciences Center - Shreveport
๐บ๐ธShreveport, Louisiana, United States
Urology Associates
๐บ๐ธBirmingham, Alabama, United States
Urology Associates, Ltd.
๐บ๐ธPhoenix, Arizona, United States
San Diego Urology Center
๐บ๐ธSan Diego, California, United States
Hillcrest Urological Medical Group
๐บ๐ธSan Diego, California, United States
Desert Urology
๐บ๐ธNorth Las Vegas, Nevada, United States
Baylor College of Medicine
๐บ๐ธHouston, Texas, United States
UCSF Cancer Center and Cancer Research Institute
๐บ๐ธSan Francisco, California, United States
Sylvester Cancer Center, University of Miami
๐บ๐ธMiami, Florida, United States
Urology Care - South
๐บ๐ธMiami, Florida, United States
Michigan Institute of Urology
๐บ๐ธDetroit, Michigan, United States
Oregon Cancer Center at Oregon Health Sciences University
๐บ๐ธPortland, Oregon, United States
Sheldon Freedman Ltd.
๐บ๐ธLas Vegas, Nevada, United States
Urology Clinic, P.C.
๐บ๐ธPortland, Oregon, United States
Vanderbilt Cancer Center
๐บ๐ธNashville, Tennessee, United States
Huntsman Cancer Institute
๐บ๐ธSalt Lake City, Utah, United States
Clinic of Urologic Wellness
๐บ๐ธLexington, Kentucky, United States
Atlantic Urological Associates
๐บ๐ธDaytona Beach, Florida, United States
Office of Jeffrey K. Cohen
๐บ๐ธPittsburgh, Pennsylvania, United States
University of California San Diego Cancer Center
๐บ๐ธLa Jolla, California, United States
Office of John Byrne
๐บ๐ธNew Rochelle, New York, United States
Herbert Irving Comprehensive Cancer Center
๐บ๐ธNew York, New York, United States
Department of Urology and Urologic Oncology
๐บ๐ธColumbus, Ohio, United States
Veterans Affairs Medical Center - Memphis
๐บ๐ธMemphis, Tennessee, United States
Ottawa General Hospital
๐จ๐ฆOttawa, Ontario, Canada
Western Urological Associates
๐บ๐ธVan Nuys, California, United States
Santa Monica Urologic Medical Group
๐บ๐ธSanta Monica, California, United States
Urology Specialists, P.C.
๐บ๐ธWaterbury, Connecticut, United States
George Washington University Hospital
๐บ๐ธWashington, District of Columbia, United States
Office of Ira W. Klimberg
๐บ๐ธOcala, Florida, United States
Affliated Urology
๐บ๐ธChicago, Illinois, United States
Urology Health Center
๐บ๐ธNew Port Richey, Florida, United States
Urology Treatment Center
๐บ๐ธSarasota, Florida, United States
Georgia Urology
๐บ๐ธAtlanta, Georgia, United States
Evanston Northwestern Healthcare
๐บ๐ธEvanston, Illinois, United States
Cambridge Urological Associates, Inc.
๐บ๐ธCambridge, Massachusetts, United States
Norris Cotton Cancer Center
๐บ๐ธLebanon, New Hampshire, United States
Veterans Affairs Medical Center - East Orange
๐บ๐ธEast Orange, New Jersey, United States
Mount Sinai Medical Center, NY
๐บ๐ธNew York, New York, United States
Urology Associates of North Texas
๐บ๐ธArlington, Texas, United States
Wilford Hall - 59th Medical Wing
๐บ๐ธLackland Air Force Base, Texas, United States
Veterans Affairs Medical Center - Temple
๐บ๐ธTemple, Texas, United States
Sentara Cancer Center
๐บ๐ธNorfolk, Virginia, United States
Office of Ronald G. Anderson
๐บ๐ธTacoma, Washington, United States
Virginia Urology Center
๐บ๐ธRichmond, Virginia, United States
Urology Center
๐บ๐ธOmaha, Nebraska, United States
University of Florida - Gainesville
๐บ๐ธGainesville, Florida, United States